Bing Pan

3.4k total citations
75 papers, 2.4k citations indexed

About

Bing Pan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bing Pan has authored 75 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 20 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bing Pan's work include Atherosclerosis and Cardiovascular Diseases (7 papers), Angiogenesis and VEGF in Cancer (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Bing Pan is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (7 papers), Angiogenesis and VEGF in Cancer (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Bing Pan collaborates with scholars based in China, United States and Romania. Bing Pan's co-authors include Lemin Zheng, Mingming Zhao, Ji Liang, Si Cheng, Changjie Liu, Mingming Zhao, Huashan Hong, Yilang Ke, Aiping Zeng and Xiaoyun Shi and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Bing Pan

72 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Pan China 25 1.2k 465 362 276 266 75 2.4k
Yan Lü China 29 1.2k 1.0× 230 0.5× 427 1.2× 279 1.0× 216 0.8× 158 2.6k
Lihong Chen China 31 990 0.8× 760 1.6× 192 0.5× 227 0.8× 285 1.1× 117 3.3k
Fan Fan United States 35 1.4k 1.2× 753 1.6× 361 1.0× 340 1.2× 354 1.3× 176 4.2k
Rui Zhao China 29 1.3k 1.1× 390 0.8× 231 0.6× 247 0.9× 249 0.9× 122 2.9k
Dongjie Li China 29 1.1k 0.9× 508 1.1× 336 0.9× 294 1.1× 377 1.4× 133 2.5k
Hongyan Li China 25 948 0.8× 232 0.5× 272 0.8× 229 0.8× 204 0.8× 89 2.4k
Xin Zhou China 30 715 0.6× 397 0.9× 238 0.7× 305 1.1× 196 0.7× 91 2.3k
Silvia Stella Barbieri Italy 26 671 0.6× 341 0.7× 191 0.5× 360 1.3× 200 0.8× 78 2.2k
Qing Zhu China 31 980 0.8× 541 1.2× 355 1.0× 204 0.7× 546 2.1× 151 3.0k
Chia‐Wei Liou Taiwan 37 1.9k 1.6× 660 1.4× 337 0.9× 227 0.8× 929 3.5× 154 4.3k

Countries citing papers authored by Bing Pan

Since Specialization
Citations

This map shows the geographic impact of Bing Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Pan more than expected).

Fields of papers citing papers by Bing Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Pan. The network helps show where Bing Pan may publish in the future.

Co-authorship network of co-authors of Bing Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Pan. A scholar is included among the top collaborators of Bing Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Pan. Bing Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Bing, et al.. (2026). JAK-STAT pathway in hematological malignancies: Achievements, challenges and future perspectives. Biomedicine & Pharmacotherapy. 195. 118959–118959.
2.
Li, Yuxiao, Ruixin Zheng, Bing Pan, et al.. (2025). Beyond monotherapy: multimodal strategies integrating immune checkpoint inhibitors in lymphoma management. Frontiers in Immunology. 16. 1713199–1713199.
3.
Zhang, Yongqiang, et al.. (2025). NETs promote invasive behavior of fibroblast-like synoviocytes through GPIbα in rheumatoid arthritis. Frontiers in Immunology. 16. 1667319–1667319. 1 indexed citations
4.
Pan, Bing, et al.. (2024). Effect of pharmacogenomic testing on the clinical treatment of patients with depressive disorder: A randomized clinical trial. Journal of Affective Disorders. 359. 117–124. 4 indexed citations
5.
Pan, Bing, et al.. (2024). Negative Affect and Impulsivity in Adolescents with Non-Suicidal Self-Injury: The Moderating and Mediating Roles of Perceived Social Support. Neuropsychiatric Disease and Treatment. Volume 21. 1–13. 1 indexed citations
7.
Pan, Bing, Fangfei Wang, Shaocheng Lyu, et al.. (2023). Spatial transcriptomics reveals the heterogeneity and FGG+CRP+ inflammatory cancer-associated fibroblasts replace islets in pancreatic ductal adenocarcinoma. Frontiers in Oncology. 13. 1112576–1112576. 3 indexed citations
8.
Chen, Linlin, et al.. (2022). Identification of inflammatory-related gene signatures to predict prognosis of endometrial carcinoma. BMC Genomic Data. 23(1). 74–74. 3 indexed citations
9.
Zhan, Rui, Mingming Zhao, Ting Zhou, et al.. (2018). Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation. Cell Death and Disease. 9(6). 683–683. 29 indexed citations
10.
Zhou, Boda, Lingyun Zu, Yong Chen, et al.. (2017). Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration. Lipids in Health and Disease. 16(1). 3–3. 20 indexed citations
11.
He, Dan, Mingming Zhao, Congying Wu, et al.. (2017). Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1. Redox Biology. 15. 228–242. 35 indexed citations
12.
Pan, Bing, et al.. (2016). Schizophrenia-like psychosis and gitelman syndrome: a case report and literature review. SpringerPlus. 5(1). 875–875. 4 indexed citations
13.
Zu, Lingyun, Chuan Ren, Bing Pan, et al.. (2015). Endothelial microparticles after antihypertensive and lipid-lowering therapy inhibit the adhesion of monocytes to endothelial cells. International Journal of Cardiology. 202. 756–759. 21 indexed citations
14.
Shen, Haitao, Enchen Zhou, Zhiwei Fu, et al.. (2015). High density lipoprotein promotes proliferation of adipose-derived stem cells via S1P1 receptor and Akt, ERK1/2 signal pathways. Stem Cell Research & Therapy. 6(1). 95–95. 22 indexed citations
15.
Dong, Shuying, Jian Kong, Jinge Kong, et al.. (2015). Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation. BMC Cancer. 15(1). 939–939. 36 indexed citations
16.
Kong, Jian, Qiangbo Zhang, Shuying Dong, et al.. (2014). YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma. Molecular Cancer. 13(1). 7–7. 38 indexed citations
17.
He, Dan, Bing Pan, Hui Ren, & Lemin Zheng. (2014). Effects of Diabetic HDL on Endothelial Cell Function. Cardiovascular & Haematological Disorders - Drug Targets. 14(2). 137–141. 4 indexed citations
18.
Pan, Bing, Baoqi Yu, Hui Ren, et al.. (2013). High-density lipoprotein nitration and chlorination catalyzed by myeloperoxidase impair its effect of promoting endothelial repair. Free Radical Biology and Medicine. 60. 272–281. 34 indexed citations
19.
Pan, Bing, Hui Ren, Yubin He, et al.. (2012). HDL of Patients with Type 2 Diabetes Mellitus Elevates the Capability of Promoting Breast Cancer Metastasis. Clinical Cancer Research. 18(5). 1246–1256. 42 indexed citations
20.
Song, Yi, Guodong Fang, Haitao Shen, et al.. (2012). Human Surfactant Protein A2 Gene Mutations Impair Dimmer/Trimer Assembly Leading to Deficiency in Protein Sialylation and Secretion. PLoS ONE. 7(10). e46559–e46559. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026